Effects of cholecystokinin on pancreatic ornithine decarboxylase gene expression.
The effects of cholecystokinin (CCK) on pancreatic ornithine decarboxylase (ODC) gene expression were studied in the rat. Plasma CCK concentrations were raised to levels comparable to postprandial values either by intravenous infusion of CCK octapeptide (CCK-8) or by intraduodenal perfusion of soybean trypsin inhibitor (SBTI). ODC mRNA levels were quantified using a cloned cDNA probe. ODC mRNA increased to 166 +/- 34% (n = 4) of control after 1 h, peaked at 254 +/- 39% (n = 4) of control after 24 h, and remained significantly elevated for up to 48 h of SBTI infusion. Intravenous infusion of CCK-8 for 24 h increased ODC mRNA levels to the same extent observed with SBTI infusion. The CCK receptor antagonist L364,718 by itself had no effect on ODC mRNA levels but totally abolished the induction of ODC mRNA by both intravenous CCK infusion and intraduodenal infusion of SBTI. These data therefore indicate that CCK plasma concentrations comparable to postprandial values regulate pancreatic ODC at a pretranslational level and that SBTI exerts its effects on pancreatic ODC via an increase in plasma CCK.
Rosewicz
S
S
Department of Physiology, University of Michigan, Ann Arbor 48109.
Lewis
L D
LD
Liddle
R A
RA
Logsdon
C D
CD
D000818:Animals; D002766:Cholecystokinin / Q000097:blood; D003001:Cloning, Molecular; D005796:Genes / Q000187:drug effects*; D008297:Male; D009955:Ornithine Decarboxylase / Q000235:genetics*; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology*; D012343:RNA, Transfer / Q000187:drug effects / Q000235:genetics*; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D012844:Sincalide / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects*; D014361:Trypsin Inhibitors / Q000494:pharmacology
D014361:Trypsin Inhibitors; D002766:Cholecystokinin; D012343:RNA, Transfer; D009955:Ornithine Decarboxylase; D012844:Sincalide